Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis.
Michael PapanicolaouAmelia L ParkerMichelle YamElysse C FilipeSunny Z WuJessica L ChittyKaitlin WyllieEmmi TranEllie MokAudrey NadaliniJoanna N SkhinasMorghan C LucasDavid HerrmannMax NobisBrooke A PereiraAndrew M K LawLesley CastilloKendelle J MurphyAnaiis ZaratzianJordan F HastingsDavid R CroucherElgene LimBrian G OliverFatima Valdes MoraBenjamin L ParkerDavid Gallego OrtegaAlexander SwarbrickSandra O'ToolePaul TimpsonThomas R CoxPublished in: Nature communications (2022)
The tumour stroma, and in particular the extracellular matrix (ECM), is a salient feature of solid tumours that plays a crucial role in shaping their progression. Many desmoplastic tumours including breast cancer involve the significant accumulation of type I collagen. However, recently it has become clear that the precise distribution and organisation of matrix molecules such as collagen I is equally as important in the tumour as their abundance. Cancer-associated fibroblasts (CAFs) coexist within breast cancer tissues and play both pro- and anti-tumourigenic roles through remodelling the ECM. Here, using temporal proteomic profiling of decellularized tumours, we interrogate the evolving matrisome during breast cancer progression. We identify 4 key matrisomal clusters, and pinpoint collagen type XII as a critical component that regulates collagen type I organisation. Through combining our proteomics with single-cell transcriptomics, and genetic manipulation models, we show how CAF-secreted collagen XII alters collagen I organisation to create a pro-invasive microenvironment supporting metastatic dissemination. Finally, we show in patient cohorts that collagen XII may represent an indicator of breast cancer patients at high risk of metastatic relapse.